LifeStance Health director Teresa DeLuca sells 20,441 shares worth $249,991.43
Reuters2026/08/14 21:51- LifeStance Health director Teresa DeLuca sold 20,441 common shares on Aug. 13, 2026 at USD 12.23.
- DeLuca held 104,593 shares following the transaction, according to a Form 4 filed on Aug. 14, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Ivy League’s space gamble: Harvard reveals $2.2 billions SpaceX position, its largest single stock holding
Harvard University Investment Management Company disclosed that it holds $2.2 billion worth of SpaceX shares, making it the largest single stock position in its $4.3 billion US equity portfolio. This holding originated from Harvard’s early investment in SpaceX through venture capital funds, and the position has significantly appreciated after SpaceX’s public listing in June this year. The University of California also disclosed a roughly $1 billion position in SpaceX during the same period. Over the past decade, endowment funds from several universities have made substantial bets on private tech assets.